Free Trading + Demat Account

Eris Lifesciences Limited IPO (Eris Lifesciences IPO) Detail

Jun 16, 2017 - Jun 20, 2017

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).

In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.

Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam. They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.

Eris Lifescience Strengths:

• Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders
• Portfolio of high volume and leading brands
• Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and concentration of specialists and super specialists
• Multi-faceted product selection and engagement model leading to growth in prescription
• Strong sales, marketing and distribution capabilities

Company Promoters:

The Promoters of the Company are:
1. Mr. Amit Indubhushan Bakshi,
2. Mr. Himanshu Jayantbhai Shah,
3. Mr. Inderjeet Singh Negi,
4. Mr. Rajendrakumar Rambhai Patel and
5. Mr. Kaushal Kamlesh Shah.

Company Financials:

Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63

Objects of the Issue:

The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

Issue Detail:

  »»  Issue Open: Jun 16, 2017 - Jun 20, 2017
  »»  Issue Type: Book Built Issue IPO
  »»  Issue Size: 28,875,000 Equity Shares of Rs 1 aggregating up to Rs 1,741.16 Cr
    ›  Offer for Sale of 28,875,000 Equity Shares of Rs 1 aggregating up to Rs [.] Cr
  »»  Face Value: Rs 1 Per Equity Share
  »»  Issue Price: Rs 600 - Rs 603 Per Equity Share
  »»  Market Lot: 24 Shares
  »»  Minimum Order Quantity: 24 Shares
  »»  Listing At: BSE, NSE

Discount to eligible employees

Eris Lifesciences is offering discount of ₹60 per share to eligible employees.

Eris Lifesciences IPO Reviews:

  1. Eris Lifesciences Limited IPO review by Dilip Davda

Eris Lifesciences IPO Recommendations:

Capital Market Review
Hem Securities - Subscribe
Angel Broking - Subscribe
ICICIDirect - Subscribe
SP Tulsian - Subscribe
Choice Equity Broking - Avoid

Issue Subscription Detail / Current Bidding Status

Number of Times Subscribed (BSE + NSE)
As on Date & TimeQIBNIIRIIEmployeeTotal
Shares Offered / Reserved8,617,5004,308,7502,872,500150,00015,948,750
Day 1 - Jun 16, 2017 17:00 IST0.07000.02000.41000.00000.1200
Day 2 - Jun 19, 2017 17:00 IST0.82000.03001.68000.33000.7500
Day 3 - Jun 20, 2017 17:00 IST4.68000.45003.51000.86003.2900

Eris Lifesciences IPO Prospectus

Eris Lifesciences IPO Rating

Rating:Rated 4.0 stars

Vote Here ...

Eris Lifesciences IPO Listing Date

  •   ›  Listing Date: Thursday, June 29, 2017
  •   ›  BSE Script Code: 540596
  •   ›  NSE Symbol: ERIS
  •   ›  Listing In: ‘B’ Group of Securities
  •   ›  ISIN: INE406M01024
  •   ›  Issue Price: Rs 603 Per Equity Share
  •   ›  Face Value: Rs 1 Per Equity Share

Listing Day Trading Information

Issue Price:
Last Trade:
Rs 603.00
Rs 612.00
Rs 592.30
Rs 627.70
Rs 601.05
Rs 603.00
Rs 611.00
Rs 593.25
Rs 628.00
Rs 601.50

Eris Lifesciences IPO News Alerts

  1. Thursday, June 29, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Listing
  2. Saturday, June 24, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Allotment
  3. Tuesday, June 20, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Close
  4. Friday, June 16, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Open

Company Contact Information

Eris Lifesciences Limited
7th Floor, Commerce House IV,
Beside Shell Petrol Pump, 100 Feet Road,
Prahladnagar, Ahmedabad 380 015
Phone: +91 79 3045 1111
Fax: +91 79 3017 9404

Eris Lifesciences IPO Registrar

Link Intime India Private Ltd   »  Report
   Link Intime India Private Ltd,
   C-13 Pannalal Silk Mills Compound,
   LBS Marg, Bhandup West, Mumbai 400078

Phone: +91-22-25963838
Fax: +91-22-25946969

Guaranteed Save 60% to 90% Brokerage + Taxes

Do you know you could reduce the brokerage cost significantly by moving to another stock broker? Our expert team compared top share brokers in India to help investors like you. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...


Eris Lifesciences IPO Review / Comments

580. ipobazaar  Aug 11, 2017 9:53:35 AM IST I Like It. | Report Abuse Reply
very poor listing....thats why GMP never guide please dont blame on market condition..SiS was listed yesterday and atleast opened on higher notes not like cochin shipyard...
i am lucky that i did not get allotment in shipyard...lets see what happens after listing...
579. VINAYERH  Aug 9, 2017 7:27:06 PM IST I Like It. | Report Abuse Reply
Chek for AFHPK6980P
578. ASNI  Aug 8, 2017 5:52:17 PM IST I Like It. | Report Abuse Reply
578.1. Compounder  Aug 9, 2017 1:39:19 AM IST I Like It. 1 | Report Abuse
Decision to sell or hold depends on your holding period. On a v conservative basis, expect the next 3 year CAGR growth to be @ 25% (2017 PAT growth was 79%) which will take the EPS to Rs. 34.3 per share. Even at a P/E multiple of 35 (reasonable for a company with 25% earnings growth and secular domestic consumption story), this stock will be at minimum Rs. 1200 by FY 20. That''s a whopping 117% return from the current price. If this return does not satisfy some people, not sure what does. This is a long term coumpounding machine run by owner operator who has skin in the game. Just hold tight for the next 2 quarters at least till the results are out and see the magic.
577. chitra kamat  Jun 16, 2017 2:22:10 PM IST I Like It. 2 | Report Abuse Reply
Here is detailed link to data including PE of listed Indian pharma companies Vs PE demanded by Eris at upper price band.
577.1. Eagleye  Aug 8, 2017 10:20:47 AM IST I Like It. | Report Abuse
IPO Guru IPO Guru (4400+ Posts, 11800+ Likes)
Eris Lifesciences IPO

Issue Price – 603

14-JUL-17 – 728.00 (High)
08-AUG-17 – 545.75 (Low)
576. Ajmera  Aug 5, 2017 6:35:51 PM IST I Like It. | Report Abuse Reply
target may be appox. 940-1000 in 3-4 month
575. Tarun D Agrawal  Jul 30, 2017 4:53:42 PM IST I Like It. | Report Abuse Reply
Will the share price go up?
575.1. Mr. Ghosh  Jul 30, 2017 5:27:17 PM IST I Like It. | Report Abuse
Wait for few days.
574. RT  Jul 26, 2017 9:20:04 PM IST I Like It. | Report Abuse Reply
Eris and Laurus both are going down.
573. DSR  Jul 24, 2017 11:16:13 PM IST I Like It. | Report Abuse Reply
This is now close to open price. I believe for those wh did not get allotment now is the god time t buy or ..should wait more for the market to correct...secondary market has become too risky ..
572. SACHIN MEHTA  Jul 19, 2017 4:58:29 PM IST I Like It. | Report Abuse Reply
Hello Sapta Sir and Eagle eye Mam...Please suggest me about Eris Lifescience..Whether we hold or sell the stock..and if hold how much time to hold for good return...and what is your views on this stock?
572.1. Raynmaker  Jul 19, 2017 5:17:27 PM IST I Like It. | Report Abuse
Wait till the first result, minimum.
571. Compounder  Jul 16, 2017 2:14:01 AM IST I Like It. | Report Abuse Reply
570. Kenny  Jun 29, 2017 12:25:53 PM IST I Like It. 5 | Report Abuse Reply
Made a loss of 150 rs.
Got saved from big loss.
Cheers 🍻

First time seen an ipo behaving like this.

From very first day #operator_driven
570.19. Raynmaker  Jul 14, 2017 8:30:45 PM IST I Like It. | Report Abuse
@kenny I don''t know what you mean. I have been posting here almost every other day, even when stock was down. Look at the Chem Cho below. I am sure if you have looked at nifty climb, you must have also seen the pharma decline in the same time. Also its the same money being rotated and I had written to wait till AU listing for locked funds to release. I won''t put in more effort to convince you of YOUR money :). Each man to himself, and God for all. All this conversation makes me understand is that There is a reason so called small investors remain small, because they don''t invest. They look for trade.
570.20. Kenny  Jul 14, 2017 9:51:03 PM IST I Like It. | Report Abuse
Noted #January2018, and i hope you make good fortune and all other who holding this share too. I am glad big guns are noting me from now on. Long way to go. Well i am in no hurry to turn my small investment to big one. In making big one wrong step here or there. Will throw me out from stock market forever and ever. I want to learn from roots, i want to grow my own tree ( long run delicious fruits ) Rather than eating some sweet or sour short term fruits. I hope you will get my point. And Raynmaker Ji, 1000 share of eris for you won''t be a big deal but for me 10 shares even matter. :) Cheers. Gn all. See you in January 18. 👍🍻
569. Dn  Jul 14, 2017 12:54:05 PM IST I Like It. | Report Abuse Reply
Bought 50 shares@714 & another 50 shares @ 702
Hold or sell
569.1. Prem Nookala  Jul 14, 2017 5:19:59 PM IST I Like It. | Report Abuse
It''s a good equity fundamentally. You could go for longterm.
568. nicks Jain  Jul 14, 2017 10:49:29 AM IST I Like It. | Report Abuse Reply
Definitely good Stocks to keep in Portfolio.
Its only for long term investors....
567. wow  Jul 14, 2017 9:08:12 AM IST I Like It. | Report Abuse Reply
its zooming now
566. Mukesh Jain  Jun 23, 2017 12:23:01 AM IST I Like It. 1 | Report Abuse Reply
my expectation from ERIS listing is like that of the Laurus Lab.

I had applied 4 lots - got 3 allotments, yet holding on to all three of them. in the whole noise around US-FDA across the whole pharma industry, Laurus was not impacted and has been a slow and study mover from 428 to approx 625 in about 6 months.

I am expecting a similar performance from Eris also, may not be a massive listing, but sure this will go in long accumulation from mutual funds and insurance co as this stock is insulated from the US-FDA.

Disclaimer - I have applied 4 lots and intend to retain all the allotments until about Rs 750-775 (25% listing gain in about 3 months or so). and my target to sell Laurus is still about 700! so holdin on to all lots there too!
566.3. STOCKT  Jun 23, 2017 2:22:01 PM IST I Like It. 2 | Report Abuse
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
Eris is good as well.its debt free.infact it''s growth rate has been even par than lauras. Both eris and lauras are long term plays
566.4. Mukesh Jain  Jul 13, 2017 11:30:50 PM IST I Like It. | Report Abuse
I am happy Eris has started to move today. I will review my position for selling around 750-775 level in coming few days, that would be clean 25% listing gain!
565. AHM  Jul 13, 2017 9:26:02 PM IST I Like It. | Report Abuse Reply
Eris Life science Fundamentally Good company
One can continue to hold for ST/MT.

Tomorrow again we will upside
Today closing price 676.95
564. RT  Jul 13, 2017 7:39:18 PM IST I Like It. 1 | Report Abuse Reply
I am Eris Lifesciences and now my turn to show the game.
563. BestAnalyst  Jul 6, 2017 8:17:15 PM IST I Like It. | Report Abuse Reply
Eris is not moving ... And tejas is running like a horse.
563.1. Raynmaker  Jul 13, 2017 3:48:19 PM IST I Like It. 1 | Report Abuse
Check now
563.2. nicks Jain  Jul 13, 2017 4:13:24 PM IST I Like It. 2 | Report Abuse
In Equity mkt, lots of patience Needed
Just Like in ERIS,we were sure and confident to keep hold
562. Septa  Jun 29, 2017 8:52:49 PM IST I Like It. 11 | Report Abuse Reply
IPO Guru IPO Guru (3900+ Posts, 3600+ Likes)
lately after the success of DMART IPO promoters have become greedy. However failure of S chand have made HNI investment more realistic.

now what is future for this counter the answer is buy on dips as i said earlier i invested in this counter on HNI quota so presently i am full. this company has superior result then it is peers the company has reported (on consolidated basis) turnover/net profits of ₹513.24 cr. / ₹70.54 cr. (FY14), ₹549.05 cr. / ₹89.26 cr. (FY15), ₹600.39 cr. / ₹134.86 cr. (FY16) and ₹744.07 cr. / ₹241.90 cr. (FY17)

With this kind of growth we could see good growth in bottom line and the PE improve. now let wait for few quarter and if they show same kind of growth ERIS will certainly rerate in time


Thank you,


Click here to follow my secondary market messages.

562.5. Raynmaker  Jul 13, 2017 3:48:55 PM IST I Like It. 1 | Report Abuse
@septa ji congratulations.
562.6. nicks Jain  Jul 13, 2017 4:12:26 PM IST I Like It. 2 | Report Abuse
Hats off to You Sirji.
561. nicks Jain  Jul 13, 2017 4:06:04 PM IST I Like It. 3 | Report Abuse Reply
Eris rocks today
Still holding 7 lots of IPO
By Popular Stock Brokers

Intraday @ 0.02%
Delivery @ 0.15%

Rs 0 account opening fee
(Rs 400 waived)

Request Demo

Flat Rs 20 Per Trade
Free Equity Delivery Trades

Rs 100 off on account opening*

Enquire Now
(* on online account opening)

ProStocks Reivew
Flat Fee Broker

Rs 899 Unlimited Equity
Rs 499 Unlimited Curr
or Rs 15 per Trade

Lowest Transaction Charge
Lowest Call & Trade Fee
Lowest Stamp Duty

FREE Trading + Demat Acct

Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading + Demat Acct
(Rs 1150 waived)

Request Call Back

RKSV Discount Broker Review  RKSV

Ditch & Switch

Switch to RKSV and earn brokerage credit of Rs 2000

Get RKSV Trading Account

More About Brokers

Special Offers Broker Reports

Message Board

Stock Message Board